Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ1BC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,898
Award facts
- Contract value 100% obligated
- $27,897.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,897.82 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors (2 ml vials) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition. Dupixent is a specialty biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, eczema, asthma, and chronic rhinosinusitis with nasal polyps, making this delivery order consistent with the company's role in supplying specialty medications and brand-name drugs to support Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ1BC?
SPE2DB25FQ1BC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQ1BC worth?
The government has obligated $27,898 on SPE2DB25FQ1BC.
Is contract SPE2DB25FQ1BC an order under another contract?
Yes. SPE2DB25FQ1BC is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1BC competed?
The extent of competition for SPE2DB25FQ1BC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award